Skip to main content
main-content

01.12.2012 | Research article | Ausgabe 1/2012 Open Access

BMC Health Services Research 1/2012

Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?

Zeitschrift:
BMC Health Services Research > Ausgabe 1/2012
Autoren:
Beverly Mielke Kocarnik, Chuan-Fen Liu, Edwin S Wong, Mark Perkins, Matthew L Maciejewski, Elizabeth M Yano, David H Au, John D Piette, Chris L Bryson
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-6963-12-391) contains supplementary material, which is available to authorized users.

Competing interests

DHA reports serving as a consultant for Bosch Inc. and receiving grants from Gilead Sciences. All other authors declare that they have no competing interests.

Authors’ contributions

BMK and CLB conceived the study. BMK, CFL, ESW, MP and CLB participated in its design. MP prepared the data for analysis and performed the statistical analyses. BMK drafted the manuscript. All authors participated in the analysis and interpretation of data and the critical revision of the manuscript for important intellectual content. CFL and CLB obtained funding for this project. All authors have read and approve the final manuscript.

Abstract

Background

Although oral hypoglycemic agents (OHAs) are an essential element of therapy for the management of type 2 diabetes, OHA adherence is often suboptimal. Pharmacists are increasingly being integrated into primary care as part of the move towards a patient-centered medical home and may have a positive influence on medication use. We examined whether the presence of pharmacists in primary care clinics was associated with higher OHA adherence.

Methods

This retrospective cohort study analyzed 280,603 diabetes patients in 196 primary care clinics within the Veterans Affairs healthcare system. Pharmacists presence, number of pharmacist full-time equivalents (FTEs), and the degree to which pharmacy services are perceived as a bottleneck in each clinic were obtained from the 2007 VA Clinical Practice Organizational Survey—Primary Care Director Module. Patient-level adherence to OHAs using medication possession ratios (MPRs) were constructed using refill data from administrative pharmacy databases after adjusting for patient characteristics. Clinic-level OHA adherence was measured as the proportion of patients with MPR >= 80%. We analyzed associations between pharmacy measures and clinic-level adherence using linear regression.

Results

We found no significant association between pharmacist presence and clinic-level OHA adherence. However, adherence was lower in clinics where pharmacy services were perceived as a bottleneck.

Conclusions

Pharmacist presence, regardless of the amount of FTE, was not associated with OHA medication adherence in primary care clinics. The exact role of pharmacists in clinics needs closer examination in order to determine how to most effectively use these resources to improve patient-centered outcomes including medication adherence.
Zusatzmaterial
Authors’ original file for figure 1
12913_2012_2359_MOESM1_ESM.tiff
Authors’ original file for figure 2
12913_2012_2359_MOESM2_ESM.tiff
Authors’ original file for figure 3
12913_2012_2359_MOESM3_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

BMC Health Services Research 1/2012 Zur Ausgabe